Clinical Trial Update: Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating brentuximab vedotin combined with chemotherapy in children and young adults with advanced Hodgkin lymphoma (stages IIB, IIIB, IVA, IVB)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Brentuximab vedotin (Adcetris) (brentuximab vedotin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Ann Arbor Stage IIB Hodgkin Lymphoma, Ann Arbor Stage IIIB Hodgkin Lymphoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-05-31